Pharma & Biotech Panel Discussion: Meeting Evolving Project Requirements to Deliver High-Value Life Science Facilities on Scope

• Interpreting shifting owner priorities and program needs to shape project strategies that reflect real world constraints and long-term goals
• Anticipating the drivers behind capital investment: how are portfolio needs evolving and how will that impact project scope?
• Understanding what end-users require from facilities to ensure project delivery aligns with operational needs, supports productivity, and maximizes long-term value

Speakers:

Steve Marr

Head of Global Facilities Delivery

Eli Lilly & Co.

Sam Rabhan

Director - Construction Management Capital Projects

Fujifilm Biotechnologies Holly Springs

William Powell

Assoc Dir

Regeneron Pharmaceuticals